CLOs on the Move

ABK Biomedical

www.abkbiomedical.com

 
ABK Biomedical Inc. combines a compelling clinical market need with innovative biomaterials invented by Drs. Bob Abraham, Daniel Boyd and Sharon Kehoe.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Organifi

Uniting the World through Health and Happiness.

MEDWRITE Medical Communications

MEDWRITE Medical Communications is a Maiden Rock, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ortonville Area Health Services

Ortonville Area Health Services is a healthcare system that includes Ortonville Hospital, Northridge Residence (nursing home), Northside Medical Clinic, Clinton Clinic, and OAHS Home Health Agency. They offer a broad scope of services to keep you and y...

CORHIO

CORHIO is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Denver, CO. To find more information about CORHIO, please visit www.corhio.org

scPharmaceuticals

scPharmaceuticals, based in Lexington, MA, is a privately held biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery. Based on widely used generic drugs that currently require intravenous or intramuscular injections, our innovative products will be administered subcutaneously via a proprietary patch pump. This avoids material risks and costs associated with the current delivery options. Our lead products are the first subcutaneous formulations of furosemide (the most widely used parenteral diuretic in treating heart failure) and ceftriaxone (the most widely used parenteral antibiotic outside the hospital setting). Our novel furosemide formulation enables convenient anytime anywhere use, for example in an outpatient setting instead of the emergency room or other in-patient settings. For ceftriaxone and other antibiotics, subcutaneous administration eliminates the need for PICCs (peripherally inserted central catheters), which are associated with serious complications, frequent adverse events and high medical cost. For further information on how we are transforming the administration of parenteral drugs.